Hepatobiliary Cancers | Proceedings from a live event held adjunct to the 2022 Gastrointestinal Cancers Symposium

Featuring perspectives from Prof Ghassan Abou-Alfa, Dr Richard Finn and Dr Robin Kelley, moderated by Dr Tanios Bekaii-Saab, including the following topics: Introduction (0:00) Advances in First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma (HCC) — Ghassan Abou-Alfa, MD, MBA (3:22) Selection and Sequencing of Therapy for Patients with Relapsed/Refractory HCC — Richard S Finn, MD (26:26) Current Treatment Strategies for Advanced Biliary Tract Cancers — Robin K Kelley, MD (46:53) Future Directions in the Management of Biliary Tract Cancer — Tanios Bekaii-Saab, MD (1:07:44) CME information and select publications